NCT04969627View on ClinicalTrials.gov

Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia.

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

January 4, 2022

Study Completion Date

March 29, 2022

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Metformin

Use Metformin for 3 months to treat PCOS

DRUG

Exenatide

Use Exenatide for 3 months to treat PCOS

Trial Locations (1)

110004

Shengjing Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

Bing He

OTHER

NCT04969627 - Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia. | Biotech Hunter | Biotech Hunter